Clinical Trials
3 trialsNCT00722553 2019-12-17
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
Acrotech Biopharma Inc.
Phase 2 Completed
NCT03193788 2017-06-21
PREMIER
Asan Medical Center
Phase 3 Unknown
NCT00216099 2016-07-29
Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer
Hoosier Cancer Research Network
Phase 2 Completed